Abstract
The musculoskeletal burden of spinal muscular atrophy (SMA) primarily involves the hip and spine. The incidence of hip instability is 30–40% and neuromuscular scoliosis is 60–90% in non-ambulatory SMA patients. The intrinsic relationship between hip and spinal deformity often requires concomitant management of the hip and spine to maximize functional and clinical outcomes. This chapter summarizes the non-operative and operative treatments for hip instability and spinal deformity in the SMA population. While hip subluxation/dislocation has traditionally been treated non-operatively in non-ambulatory SMA patients, the intra-thecal administration of Nusinersen has changed the functional and ambulatory prognosis of patients with SMA. Thus, orthopedic surgeons should consider treating hip instability with operative hip reconstruction as the surgical complication and recurrence rate is similar to that in other neuromuscular conditions.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Canavese F, Sussman MD. Strategies of hip management in neuromuscular disorders: Duchenne Muscular Dystrophy, Spinal Muscular Atrophy, Charcot-Marie-Tooth Disease and Arthrogryposis Multiplex Congenita. Hip Int. 2009;19(Suppl 6):S46–52.
Lunn MR, Wang CH. Spinal muscular atrophy. Lancet. 2008;371(9630):2120–33.
Prior TW, Finanger E. Spinal muscular atrophy. In: Adam MP, et al., editors. GeneReviews((R)). Seattle, WA: University of Washington; 1993.
Sporer SM, Smith BG. Hip dislocation in patients with spinal muscular atrophy. J Pediatr Orthop. 2003;23(1):10–4.
Shapiro F, Specht L. The diagnosis and orthopaedic treatment of childhood spinal muscular atrophy, peripheral neuropathy, Friedreich ataxia, and arthrogryposis. J Bone Joint Surg Am. 1993;75(11):1699–714.
Larson J, Snyder J, Troy M, Whitaker AT, Snyder B. Short-term clinical outcomes of hip reconstructive surgery in patients with spinal muscular atrophy. In: American Academy of pediatrics section on orthopedics, November 3, 2018. Orlando, Florida.
Finkel RS, et al. Nusinersen versus sham control in infantile-onset spinal muscular atrophy. N Engl J Med. 2017;377(18):1723–32.
Lefebvre S, et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell. 1995;80(1):155–65.
Sugarman EA, et al. Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >72,400 specimens. Eur J Hum Genet. 2012;20(1):27–32.
Abresch RT, et al. Assessment of pain and health-related quality of life in slowly progressive neuromuscular disease. Am J Hosp Palliat Care. 2002;19(1):39–48.
Mesfin A, Sponseller PD, Leet AI. Spinal muscular atrophy: manifestations and management. J Am Acad Orthop Surg. 2012;20(6):393–401.
Zenios M, et al. Operative treatment for hip subluxation in spinal muscular atrophy. J Bone Joint Surg Br. 2005;87(11):1541–4.
Ogino S, Wilson RB. Spinal muscular atrophy: molecular genetics and diagnostics. Expert Rev Mol Diagn. 2004;4(1):15–29.
Lally C, et al. Indirect estimation of the prevalence of spinal muscular atrophy Type I, II, and III in the United States. Orphanet J Rare Dis. 2017;12(1):175.
Patel J, Shapiro F. Simultaneous progression patterns of scoliosis, pelvic obliquity, and hip subluxation/dislocation in non-ambulatory neuromuscular patients: an approach to deformity documentation. J Child Orthop. 2015;9(5):345–56.
Mercuri E, Bertini E, Iannaccone ST. Childhood spinal muscular atrophy: controversies and challenges. Lancet Neurol. 2012;11(5):443–52.
Phillips DP, et al. Surgical treatment of scoliosis in a spinal muscular atrophy population. Spine (Phila Pa 1976). 1990;15(9):942–5.
Fujak A, et al. Contractures of the lower extremities in spinal muscular atrophy type II. Descriptive clinical study with retrospective data collection. Ortop Traumatol Rehabil. 2011;13(1):27–36.
Finkel RS, Sejersen T, Mercuri E. 218th ENMC International Workshop, in Revisiting the Consensus on Standards of Care in SMA. Naarden, The Netherlands: ENMC SMA Workshop Study Group; 2016.
Glanzman AM, et al. The Children’s Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND): test development and reliability. Neuromuscul Disord. 2010;20(3):155–61.
Mazzone E, et al. Six minute walk test in type III spinal muscular atrophy: a 12 month longitudinal study. Neuromuscul Disord. 2013;23(8):624–8.
Mazzone E, et al. Assessing upper limb function in nonambulant SMA patients: development of a new module. Neuromuscul Disord. 2011;21(6):406–12.
Vuillerot C, et al. Responsiveness of the motor function measure in patients with spinal muscular atrophy. Arch Phys Med Rehabil. 2013;94(8):1555–61.
Montes J, et al. Six-Minute Walk Test demonstrates motor fatigue in spinal muscular atrophy. Neurology. 2010;74(10):833–8.
Livingston K, et al. Parasol rib deformity in hypotonic neuromuscular scoliosis: a new radiographic definition, and a comparison of short-term treatment outcomes with VEPTR and growing rods. Spine (Phila Pa 1976). 2015;40(13):E780–6.
Evers MM, Toonen LJ, van Roon-Mom WM. Antisense oligonucleotides in therapy for neurodegenerative disorders. Adv Drug Deliv Rev. 2015;87:90–103.
Mendell JR, et al. Single-dose gene-replacement therapy for spinal muscular atrophy. N Engl J Med. 2017;377(18):1713–22.
A study for participants with spinal muscular atrophy (SMA) who previously participated in nusinersen (ISIS 396443) investigational studies. (SHINE). https://clinicaltrials.gov/ct2/show/NCT02594124. (Identification No. NCT02594124).
Ruzbarsky JJ, et al. Risk factors and complications in hip reconstruction for nonambulatory patients with cerebral palsy. J Child Orthop. 2013;7(6):487–500.
McHale KA, Bagg M, Nason SS. Treatment of the chronically dislocated hip in adolescents with cerebral palsy with femoral head resection and subtrochanteric valgus osteotomy. J Pediatr Orthop. 1990;10(4):504–9.
Wang HY, et al. Joint range of motion limitations in children and young adults with spinal muscular atrophy. Arch Phys Med Rehabil. 2004;85(10):1689–93.
Robinson D, et al. Scoliosis and lung function in spinal muscular atrophy. Eur Spine J. 1995;4(5):268–73.
Chng SY, et al. Pulmonary function and scoliosis in children with spinal muscular atrophy types II and III. J Paediatr Child Health. 2003;39(9):673–6.
McElroy MJ, et al. Growing rods for scoliosis in spinal muscular atrophy: structural effects, complications, and hospital stays. Spine (Phila Pa 1976). 2011;36(16):1305–11.
Chandran S, et al. Early treatment of scoliosis with growing rods in children with severe spinal muscular atrophy: a preliminary report. J Pediatr Orthop. 2011;31(4):450–4.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Larson, J.E., Snyder, B. (2019). The Hip in Spinal Muscular Atrophy. In: Alshryda, S., Howard, J., Huntley, J., Schoenecker, J. (eds) The Pediatric and Adolescent Hip. Springer, Cham. https://doi.org/10.1007/978-3-030-12003-0_20
Download citation
DOI: https://doi.org/10.1007/978-3-030-12003-0_20
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-12002-3
Online ISBN: 978-3-030-12003-0
eBook Packages: MedicineMedicine (R0)